Gaudium IVF reported a 9.1% revenue increase to Rs 19.4 crore in Q1 FY27. However, EBITDA margins dropped significantly to 12.5% due to expansion costs. The company expects margins to recover as new centers mature.
Gaudium IVF Reports Q1 FY27 Growth Amidst Margin Pressure
Revenue from operations: Rs 19.4 crore (up 9.1% YoY) PAT: Rs 1.8 crore (down 42.27% YoY) Reader Takeaway: Revenue growth signals expansion success; margin recovery hinges on new hub performance. ## What just happened Gaudium IVF and Women Health Ltd. posted its financial results for the first quarter of FY27. The company's revenue from operations saw a 9.1% year-on-year increase, reaching Rs 19.4 crore from Rs 17.8 crore in Q1 FY26. However, profitability was impacted, with Profit After Tax (PAT) declining by 42.27% to Rs 1.8 crore. ## Why this matters The key concern for investors is the significant drop in EBITDA margin, which fell from 29.0% in Q1 FY26 to 12.5% in Q1 FY27. This compression is attributed to substantial front-loaded expenses related to the company's aggressive expansion plans. ## The backstory Gaudium IVF is currently in a growth phase, aiming to establish 10 new hubs in FY27. This includes pre-operational costs, hiring of clinical talent, and integration of new AI tools for embryology. The company also plans to launch a 'Gaudium Women Hospital' in Lucknow. ## What changes now Management anticipates that margins will gradually improve and normalize towards historical levels by the end of FY27 as the newly opened centers mature and contribute to revenue. They are confident in achieving their guidance of approximately 30% year-on-year revenue growth for the full fiscal year. ## Risks to watch Investors should closely monitor the ramp-up and operational efficiency of the new hubs. The successful integration and cost management of these expansions will be crucial for margin recovery. Additionally, the evolving regulatory landscape for Assisted Reproductive Technology (ART) and Surrogacy Acts across different states remains a point to watch. ## Peer comparison While specific peer data isn't in the filing, Gaudium IVF's strategy involves significant capital expenditure on new centers, which is a common approach for scaling in the fertility and women's health sector. The company highlighted its debt-to-equity ratio of approximately 0.04x, indicating a conservative financing approach. ## Context metrics (time-bound) * Q1 FY27 Revenue: Rs 19.4 crore (up 9.1% from Rs 17.8 crore in Q1 FY26). * Q1 FY27 EBITDA Margin: 12.5% (down from 29.0% in Q1 FY26). * EBITDA adjusted for one-offs: Rs 5.35 crore (~27.63% margin). * Target: 10 new hubs in FY27. * Lucknow hospital project cost: Up to Rs 15 crore. ## What to track next Investors will be keen to see the financial performance of the newly operational South Extension hub and the two upcoming centers. Tracking the EBITDA margin recovery through the remaining quarters of FY27 will be critical, alongside updates on the Lucknow hospital project.
